help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0554
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, W.
Right arrow Articles by Ilio, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, W.
Right arrow Articles by Ilio, K.
Endocrinology Vol. 144, No. 10 4280-4284
Copyright © 2003 by The Endocrine Society


BRIEF COMMUNICATION

Dual Regulation of Proliferation and Growth Arrest in Prostatic Stromal Cells by Transforming Growth Factor-ß1

Wei Zhou, Irwin Park, Michael Pins, James M. Kozlowski, Borko Jovanovic, Ju Zhang, Chung Lee and Kenneth Ilio

Departments of Urology (W.Z., I.P., J.M.K., C.L., K.I.), Pathology (M.P.), and Preventive Medicine (B.J.), Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611; and Institute of Molecular Biology (J.Z.), Nankai University, Tainjing 300071, China

Address all correspondence and requests for reprints to: Dr. Chung Lee, Department of Urology, Tarry 16-733, 303 East Chicago Avenue, Chicago, Illinois 60611.

Abstract

In a preliminary study, we observed that TGF-ß1 induced both proliferation and growth arrest in prostatic stromal cells, depending on the concentration of TGF-ß1 used in the culture medium. In this study, we explored possible mechanisms of this dual effect of TGF-ß. Primary cultures of prostatic stromal cells, established from clinical surgical specimens and treated with low doses of TGF-ß1 (0.001–0.01 ng/ml), resulted in an increase in cell proliferation. The addition of neutralizing antibody against platelet-derived growth factor (PDGF)-BB, but not anti-PDGF-AA, abrogated this stimulatory effect of TGF-ß1. TGF-ß1 treatment resulted in a dose-related increase in PDGF-BB production as measured by ELISA. Cells underwent growth arrest at high concentrations of TGF-ß1 (1.0 and 10 ng/ml). An inhibitor of cyclin-dependent kinase (cdk), p15INK4b, was up-regulated at both transcript and protein levels in these cultures by TGF-ß1 in a dose-related manner as determined by RT-PCR and Western blot analysis. The transcript, but not the protein, for another cdk inhibitor, p21Cip1, was up-regulated with treatment of TGF-ß1 to these cells. Levels of other cdk inhibitors, such as p16INK4a and p27Kip1, were constitutively expressed in prostatic stromal cells and were not significantly affected by TGF-ß1 treatment. Finally, the growth arrest effect of TGF-ß1 was abrogated when antisense oligonucleotides to p15INH4b, but not p21Cip1, were added to the culture medium. These data indicate that the dual effect of TGF-ß1 is mediated, at least, by up-regulation of PDGF-BB and p15INK4b, respectively.




This article has been cited by other articles:


Home page
EndocrinologyHome page
I. I. Park, Q. Zhang, V. Liu, J. M. Kozlowski, J. Zhang, and C. Lee
17{beta}-Estradiol at Low Concentrations Acts through Distinct Pathways in Normal Versus Benign Prostatic Hyperplasia-Derived Prostate Stromal Cells
Endocrinology, October 1, 2009; 150(10): 4594 - 4605.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H.-J. Kim, L. C. Andersson, D. Bouton, M. Warner, and J.-A. Gustafsson
Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice
PNAS, January 13, 2009; 106(2): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Li, C.-L. Wu, P. G. Febbo, and A. F. Olumi
Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells
Am. J. Pathol., October 1, 2007; 171(4): 1189 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. T. Lee, J. H. Hong, C. Kwak, J. Woo, V. Liu, C. Lee, and I. Y. Kim
Effect of Dominant Negative Transforming Growth Factor-{beta} Receptor Type II on Cytotoxic Activity of RAW 264.7, a Murine Macrophage Cell Line
Cancer Res., July 15, 2007; 67(14): 6717 - 6724.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Q. Zhang, J. N. Rubenstein, T. L. Jang, M. Pins, B. Javonovic, X. Yang, S.-J. Kim, I. Park, and C. Lee
Insensitivity to Transforming Growth Factor-{beta} Results from Promoter Methylation of Cognate Receptors in Human Prostate Cancer Cells (LNCaP)
Mol. Endocrinol., September 1, 2005; 19(9): 2390 - 2399.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. C. Tomlinson, S. H. Freestone, O. C. Grace, and A. A. Thomson
Differential Effects of Transforming Growth Factor-{beta}1 on Cellular Proliferation in the Developing Prostate
Endocrinology, September 1, 2004; 145(9): 4292 - 4300.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society